BSE Live
Dec 26, 16:01Prev. Close
424.45
Open Price
422.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:59Prev. Close
422.00
Open Price
420.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
417.30 (4)
| Balance Sheet of Aarti Drugs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 91.27 | 91.94 | 92.60 | 92.60 | 93.20 | |
| Total Share Capital | 91.27 | 91.94 | 92.60 | 92.60 | 93.20 | |
| Reserves and Surplus | 1,160.08 | 1,083.27 | 1,021.70 | 879.57 | 766.41 | |
| Total Reserves and Surplus | 1,160.08 | 1,083.27 | 1,021.70 | 879.57 | 766.41 | |
| Total Shareholders Funds | 1,251.35 | 1,175.21 | 1,114.30 | 972.17 | 859.61 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 237.95 | 238.26 | 161.89 | 118.33 | 147.56 | |
| Deferred Tax Liabilities [Net] | 73.26 | 69.73 | 68.37 | 70.04 | 74.97 | |
| Other Long Term Liabilities | 1.01 | 1.08 | 12.84 | 11.44 | 10.85 | |
| Long Term Provisions | 3.44 | 2.74 | 7.11 | 7.86 | 22.12 | |
| Total Non-Current Liabilities | 315.65 | 311.81 | 250.20 | 207.67 | 255.50 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 275.97 | 234.60 | 371.20 | 396.55 | 142.18 | |
| Trade Payables | 373.11 | 393.29 | 419.01 | 416.19 | 293.04 | |
| Other Current Liabilities | 53.51 | 55.18 | 38.16 | 39.35 | 85.40 | |
| Short Term Provisions | 3.20 | 1.53 | 2.63 | 2.59 | 1.28 | |
| Total Current Liabilities | 705.79 | 684.60 | 830.99 | 854.68 | 521.89 | |
| Total Capital And Liabilities | 2,272.79 | 2,171.62 | 2,195.50 | 2,034.52 | 1,637.01 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 761.12 | 722.08 | 634.17 | 649.35 | 630.41 | |
| Intangible Assets | 0.12 | 0.21 | 0.31 | 0.07 | 0.11 | |
| Capital Work-In-Progress | 273.40 | 221.62 | 160.75 | 59.62 | 15.95 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 1,034.63 | 943.92 | 795.23 | 709.03 | 646.47 | |
| Non-Current Investments | 42.40 | 29.97 | 28.62 | 28.03 | 24.32 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 15.20 | 16.71 | 22.11 | 24.26 | 6.09 | |
| Total Non-Current Assets | 1,092.23 | 990.60 | 845.96 | 761.33 | 676.88 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 407.23 | 441.77 | 477.73 | 488.46 | 390.38 | |
| Trade Receivables | 701.72 | 643.95 | 801.68 | 711.64 | 503.99 | |
| Cash And Cash Equivalents | 4.57 | 3.82 | 2.68 | 2.21 | 3.81 | |
| Short Term Loans And Advances | 0.13 | 0.19 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 66.90 | 91.29 | 67.45 | 70.88 | 61.96 | |
| Total Current Assets | 1,180.56 | 1,181.02 | 1,349.53 | 1,273.19 | 960.13 | |
| Total Assets | 2,272.79 | 2,171.62 | 2,195.50 | 2,034.52 | 1,637.01 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 280.63 | 266.61 | 258.17 | 194.24 | 152.85 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 42.40 | 823.86 | 908.22 | 861.20 | 752.42 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 2.67 | 6.00 | 8.44 | 0.79 | 4.97 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 12.17 | 8.72 | 18.56 | 12.21 | 12.71 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 675.77 | 672.84 | 853.64 | 775.37 | 600.09 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 87.02 | 87.02 | 87.02 | 87.02 | 87.59 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 42.40 | 29.97 | 28.62 | 28.03 | 24.32 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y